Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2006; 12(30): 4794-4806
Published online Aug 14, 2006. doi: 10.3748/wjg.v12.i30.4794
Published online Aug 14, 2006. doi: 10.3748/wjg.v12.i30.4794
Drug | Methotrexate |
Dosage | 25 mg/wk i.m., if remission is achieved reduce to 15 i.m. (or s.c.) |
Indications | Maintenance, chronically active disease, steroid-refractory and steroid-dependency, fistulae |
Important side effects | Nausea, abdominal pain, diarrhea, stomatitis; hepatitis, liver fibrosis; hypersensivity pneumonitis |
Monitoring | Liver function and full blood count monthly for the first two months, if normal then every two months throughout therapy |
Pregnancy | Strictly prohibited |
Comments | Entire therapeutic efficacy is observed mostly after 2-4 mo; consider folic acid supplementation with 2.5-5 mg/d; ensure adequate birth control; allow 3 mo time before pregnancy or conceiving |
- Citation: Büning C, Lochs H. Conventional therapy for Crohn’s disease. World J Gastroenterol 2006; 12(30): 4794-4806
- URL: https://www.wjgnet.com/1007-9327/full/v12/i30/4794.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i30.4794